Randomized phase III trial of carboplatin(C) plus etoposide (E) vs. split doses of cisplatin (P) plus etoposide (E) in elderly or poor-risk patients with extensive disease small cell lung cancer (ED-SCLC): JCOG9702

被引：0
|
作者：
Okamoto, H
Watanabe, K
Kunikane, H
Yokoyama, A
Kudoh, S
Ishizuka, N
Fukuda, H
Tamura, T
Saijo, N
机构：
[1] Yokohama Municipal Citizens Hosp, Yokohama, Kanagawa, Japan
[2] Niigata Canc Ctr Hosp, Niigata, Japan
[3] Osaka City Univ, Sch Med, Osaka 545, Japan
[4] Natl Canc Ctr, Tokyo 104, Japan
[5] Natl Canc Ctr, Tokyo, Japan
[6] Natl Canc Ctr E Hosp, Kashiwa, Chiba, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：623S / 623S
页数：1
相关论文
共 50 条
  • [1] Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702
    H Okamoto
    K Watanabe
    H Kunikane
    A Yokoyama
    S Kudoh
    T Asakawa
    T Shibata
    H Kunitoh
    T Tamura
    N Saijo
    [J]. British Journal of Cancer, 2007, 97 : 162 - 169
  • [2] Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702
    Okamoto, H.
    Watanabe, K.
    Kunikane, H.
    Yokoyama, A.
    Kudoh, S.
    Asakawa, T.
    Shibata, T.
    Kunitoh, H.
    Tamura, T.
    Saijo, N.
    [J]. BRITISH JOURNAL OF CANCER, 2007, 97 (02) : 162 - 169
  • [3] Randomized phase III trial of carboplatin (Cb) or cisplatin (P) in combination with etoposide (E) in elderly or poor-risk patients with extensive disease small cell lung cancer (ED-SCLC): Report of a Japan Clinical Oncology Group Trial (JCOG9702)
    Kunitoh, H
    Okamoto, H
    Watanabe, K
    Kunikane, H
    Yokoyama, A
    Kudoh, S
    Ishizuka, N
    Fukuda, H
    Tamura, T
    Saijo, N
    [J]. LUNG CANCER, 2005, 49 : S53 - S53
  • [4] Carboplatin (C) and etoposide (E) in previously untreated extensive stage small cell lung cancer (ED-SCLC)
    Yilmaz, U.
    Halilcolar, H.
    Yildirim, Y.
    Yapicioglu, S.
    Unsal, I.
    Kuzer, P.
    Altiparmak, O.
    Cinar, T.
    [J]. LUNG CANCER, 2006, 52 : S43 - S43
  • [5] A randomized phase III trial of irinotecan plus carboplatin versus etoposide plus carboplatin in patients with small cell lung cancer, extensive disease (SCLC-ED): IRIS-Study
    Hermes, A.
    Bergman, B.
    Bremnes, R.
    Ek, L.
    Fluge, S.
    Sederholm, C.
    Sundstrom, S.
    Thaning, L.
    Vilsvik, J.
    Aasebo, U.
    Sorenson, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] PHASE III TRIAL COMPARING IRINOTECAN PLUS CISPLATIN (IP) WITH ETOPOSIDE PLUS CISPLATIN (EP) IN KOREAN PATIENTS WITH EXTENSIVE DISEASE (ED) SMALL CELL LUNG CANCER (SCLC)
    Kim, Dong-Wan
    Kim, Hoon-Gu
    Kim, Joo-Hang
    Park, Keunchil
    Kim, Hoon Kyo
    Jang, Joung Soon
    Kim, Bong-Seog
    Kang, Jin-Hyoung
    Lee, Kyung Hee
    Kim, Sang-We
    Ryoo, Hun Mo
    Kim, Jin-Soo
    Lee, Ki Hyeong
    Kwon, Jung Hye
    Choi, Jin-Hyuk
    Hong, Dae Sik
    Shin, Sang Won
    Hahn, Seokyung
    Heo, Dae Seog
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S219 - S220
  • [7] Randomized phase II trial of irinotecan plus cisplatin (IP) versus irinotecan, cisplatin plus etoposide (IPE) every three weeks in patients with extensive disease small cell lung cancer (ED-SCLC).
    Sekine, I.
    Nokihara, H.
    Takeda, K.
    Nishiwaki, Y.
    Nakagawa, K.
    Isobe, H.
    Mori, K.
    Matsui, K.
    Saijo, N.
    Tamura, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 385S - 385S
  • [8] A randomized phase II trial of irinotecan plus carboplatin versus etoposide plus carboplatin in patients with extensive disease small cell lung cancer
    Schmittel, A.
    Fischer von Weikersthal, L.
    Sebastian, M.
    Schulze, K.
    Link, H.
    Thiel, E.
    Keilholz, U.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 327 - 328
  • [9] Irinotecan plus carboplatin versus etoposide plus carboplatin in extensive disease small cell lung cancer: Results of the German randomized phase III trial
    Schmittel, A. H.
    Sebastian, M.
    von Weikersthal, L. Fischer
    Gauler, T.
    Hortig, P.
    Fischer, J. R.
    Link, H.
    Binder, D.
    Eberhardt, W.
    Keilholz, U.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [10] Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer:: A Randomized phase III trial
    Hermes, Andreas
    Bergman, Bengt
    Bremnes, Roy
    Ek, Lars
    Fluge, Sverre
    Sederholm, Christer
    Sundstrom, Stein
    Thaning, Lars
    Vilsvik, Jan
    Aasebo, Ulf
    Soerenson, Sverre
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (26) : 4261 - 4267
12345